Macula displacement common after RRD repair

Article

Macula displacement is common after rhematogenous retinal detachment (RRD) repair and is heterogenous in nature, reveals a recent study.

Macula displacement is common after rhematogenous retinal detachment (RRD) repair and is heterogenous in nature, reveals a recent study.

A team headed by Dr Edward Lee, Department of Ophthalmology, St Thomas’ Hospital, London, UK, postoperatively investigated patients undergoing primary RRD repair using fundus autofluorescence and OCT imaging. The results were assessed for correlations with symptoms and preoperative features.

In 72% of 32 consecutive fovea-involving detachments treated with vitrectomy and gas macula displacement was evident. This was also seen in 29.4% of foveal-sparing cases treated with vitrectomy and gas and in all patients with fovea-involving cases with detachments treated by vitrectomy and oil.

The results revealed a significant correlation between the presence of macula displacement and symptoms of distortion in the early postoperative period. Patients with symptoms described bending of lines with or without objects appearing as smaller or narrower in the operated eye. The extent of displacement was linked with distance from the optic disc and the extent of retinal detachment.

The group discovered that most affected patient, who underwent RRD repair, are symptomatic in the early postoperative period.

The abstract can be found in the British Journal of Ophthalmology.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.